C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2011
10/27/2011	US20110262347 Methods and compositions for enhanced delivery of compounds
10/27/2011	CA2834001A1 Method for the identification of t cell epitopes
10/26/2011	EP2380597A1 Cyclopeptide derivatives and uses thereof
10/26/2011	EP2380596A1 Cyclopentapeptide derivatives and uses thereof
10/26/2011	EP2380591A2 Vaccine peptide combinations against cat allergy
10/26/2011	EP2379580A1 Novel antibacterial agents for the treatment of gram positive infections
10/26/2011	EP2378875A1 Cell-permeant peptide-based inhibitor of kinases
10/26/2011	EP1802650B1 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
10/26/2011	EP1692158B1 Vegf binding and supported peptides for treating skin diseases
10/26/2011	EP0787191B2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
10/26/2011	CN102227442A Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
10/26/2011	CN102225966A Method for solid phase peptide synthesis
10/26/2011	CN102225965A Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof
10/26/2011	CN102225964A Self-assembling peptide amphiphiles and related methods for growth factor delivery
10/26/2011	CN102225963A Method for reducing acetonitrile residue in polypeptide medicament
10/26/2011	CN101838311B Mimic short peptide 7B of endothelial cell growth factor VEGF antigen epitope and application thereof
10/25/2011	US8044195 Cross-linked glycopeptide-cephalosporin antibiotics
10/25/2011	US8044176 Carbon nanotube binding peptides
10/25/2011	US8044175 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/25/2011	US8044174 Thrombopoietic compounds
10/25/2011	US8044027 Utilization of peptides as active ingredients for slimming
10/25/2011	US8044022 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
10/25/2011	US8044019 Cell penetrating peptide
10/25/2011	US8044018 Reagents and methods for smooth muscle therapies
10/25/2011	CA2437983C Transporters comprising spaced arginine moieties
10/20/2011	WO2011127835A1 Purification method of azacyclohexapeptide or its salt
10/20/2011	WO2011127624A1 Anti-hiv peptide
10/20/2011	WO2011084685A3 Saposin-a derived peptides and uses thereof
10/20/2011	WO2011066521A3 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
10/20/2011	US20110258712 Myostatin isoform
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257086 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
10/20/2011	US20110257082 Hiv-1 integrase derived stimulatory peptides interfering with integrase -- rev protein binding
10/20/2011	US20110257081 Multigand constructs
10/20/2011	US20110257027 Gamma-secretase substrate and methods of use
10/20/2011	US20110256567 Fluorescent cyclic peptides, preparation method thereof and use of these peptides for measuring the enzymatic activity of a protease enzyme
10/20/2011	US20110256145 Connective Tissue Growth Factor-3 (CTGF-3)
10/20/2011	US20110256139 Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor
10/20/2011	US20110256058 Novel Peptides and Uses Thereof
10/19/2011	EP2377878A1 Potent compstatin analogs
10/19/2011	EP2377877A1 Potent compstatin analogs
10/19/2011	EP2377579A1 Cyclic peptide CXCR4 antagonists
10/19/2011	EP2377548A2 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
10/19/2011	EP2376524A1 Derivatives of cyclosporin a
10/19/2011	EP2376449A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
10/19/2011	EP1573323B1 Prion protein ligands and methods of use
10/19/2011	EP1383793B1 Insulin and igf-1 receptor agonists and antagonists
10/19/2011	CN1938332B Inhibitors of serine proteases, particularly HCV NS3-HS4A protease
10/19/2011	CN102224168A Composition for producing anti-amyloid beta peptide antibodies with d-peptides
10/19/2011	CN102224162A Bipodal peptide binder
10/19/2011	CN102219833A Safer preparation method of echinocandin antifungal medicament
10/19/2011	CN102219832A Purifying method of azacyclohexapeptides or salts thereof
10/19/2011	CN102219831A Antibiotic peptide as well as preparation method and application thereof
10/19/2011	CN102219830A Oxidation resisting polypeptide and preparation method thereof
10/19/2011	CN102219829A Antioxidant polypeptide prepared by enzymatic hydrolysis of sharkskin collagen with acid protease
10/19/2011	CN102219828A Antioxidation polypeptide prepared from sharkskin collagen
10/19/2011	CN101429233B Polyglycol modified antimicrobial peptide and uses thereof
10/18/2011	US8039623 Peptidomimetics compound; viricides; interference in life cycle og hepatitis c virus
10/18/2011	US8039585 for use in treatment and prevention of vision defects and cell proliferative disorders
10/18/2011	US8039584 Carbon nanotube binding peptides
10/18/2011	US8039583 Carbon nanotube binding peptides
10/18/2011	US8039582 Peptide networks
10/18/2011	US8039440 Peptides for inhibiting chemokine binding to chemokine receptors
10/18/2011	US8039438 Amino acid sequences for use in treatment and prevention of cell proliferative disorders; antitumor agents
10/18/2011	US8039227 Peptide biomarkers predictive of renal function decline and kidney disease
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	CA2446189C Peptides and related molecules that bind to tall-1
10/13/2011	WO2011126882A2 Therapeutic peptides and their derivatives and therapeutic uses thereof
10/13/2011	WO2011126054A1 Physiologically active peptides
10/13/2011	WO2011126010A1 Cancer cell-specific cell-penetrating peptide and use thereof
10/13/2011	WO2011125334A1 Cdca5 peptides and vaccines including the same
10/13/2011	WO2011125139A1 Cluap1 peptides and vaccines including the same
10/13/2011	WO2011124031A1 Polypeptide conjugate of paclitaxel or docetaxel
10/13/2011	WO2011103583A3 Methods and compositions related to anti-angiogenic peptides
10/13/2011	WO2011071927A3 Treatments for gastrointestinal disorders
10/13/2011	WO2011064779A3 Peptides derived from hiv-1 gp41 transmembrane for t - immunomodulation
10/13/2011	WO2011063419A3 Lipopeptide compositions and related methods
10/13/2011	US20110251372 Process for the production of bivalirudin
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011	US20110251140 Peptide antagonist of interleukin-15 activity
10/13/2011	US20110251138 Lipoic acid metabolite conjugate: preparation and their therapeutic effect
10/13/2011	US20110251128 THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
10/13/2011	US20110251120 Antimicrobial Peptides and Methods of Identifying the Same
10/13/2011	US20110250704 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
10/13/2011	US20110250702 Isolated peptides of rabbit factor vii
10/13/2011	US20110250587 Novel method for generation of rna virus
10/13/2011	US20110250221 Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
10/13/2011	US20110250219 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
10/13/2011	US20110250218 Disease-Associated Antigens and Methods of Use Thereof
10/13/2011	US20110250213 Antibodies to cd122
10/13/2011	US20110250202 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus
10/13/2011	US20110250180 Ccn3 peptides and analogs thereof for therapeutic use
10/13/2011	US20110250153 Oligomeric biosurfactants in dermatocosmetic compositions
10/13/2011	US20110250144 Rgd-containing peptidomimetics and uses thereof
10/13/2011	US20110250133 Gastrin releasing peptide compounds
10/13/2011	CA2795534A1 Cdca5 peptides and vaccines including the same
10/13/2011	CA2795423A1 Cluap1 peptides and vaccines including the same
10/12/2011	EP2374465A1 Peptide-based conditioners and colorants for hair, skin and nails
10/12/2011	EP2374454A1 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/12/2011	EP2373998A1 Nitroprotein biomarkers for copd

1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 423